drugset / Trial / NCT06848946
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
RandomizedParallel-groupDouble-blindTreatment
Summary
This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Timeline
- Start
- 2025-01-13
- Primary completion
- 2026-08
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost | Other / unclassified | 75 ug | Other |